Showing 50 news articles about Treatment simplification strategies

Filters Content type: News Topic: Treatment simplification strategies

Research into HIV treatment strategies in which the number of antiretroviral drugs or frequency of dosing is reduced. Some dual therapy regimens have proven to be safe and effective.

Resistance

Lamivudine resistance mutation may persist for many years in some people with HIV

News
4 July 2024
Hepatitis B

Hidden hepatitis B infection may compromise dolutegravir / lamivudine treatment

News
7 May 2024
Resistance

New HIV drugs should be classed as inferior if they carry a higher risk of resistance

News
22 December 2023
Resistance

Dolutegravir resistance is rare, but some risk factors can up the odds

News
6 December 2023
Treatment simplification strategies

Reduced-drug treatment becoming common in Paris

News
23 October 2023
Treatment simplification strategies

Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure

News
20 October 2023
New & experimental HIV treatments

Doravirine/islatravir just as effective as Biktarvy in previously untreated people

News
24 July 2023
HIV treatment for children & young people

NRTI-sparing regimen effective for children and adolescents

News
21 July 2023
Treatment simplification strategies

Dolutegravir alone maintains HIV suppression in those treated early

News
28 June 2023
Treatment simplification strategies

Real-world data confirm the efficacy of dolutegravir-based dual therapy

News
29 May 2023
Changing treatment

Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment

News
23 February 2023
Resistance

Are people with a shorter history of viral suppression at greater risk of failure of dolutegravir/lamivudine?

News
6 October 2022
Treatment simplification strategies

History of drug resistance or virological failure warrants caution when switching to dolutegravir plus lamivudine

News
30 December 2021
Treatment simplification strategies

Four-days-on, three-days-off treatment regimen still looks effective after two years

News
16 March 2021
Treatment simplification strategies

Similar rate of severe clinical outcomes with two drug vs three drug HIV treatment combinations

News
17 February 2021
New & experimental HIV treatments

Islatravir plus doravirine remains effective at 96 weeks

News
9 October 2020
Injectable & long-acting HIV treatment

Long-acting injectables might be administered every two months

News
11 March 2020
Treatment simplification strategies

Options for two-drug simplification expand

News
14 November 2019
Treatment simplification strategies

Dolutegravir dual therapy works well for both first line and maintenance treatment

News
29 July 2019
New & experimental HIV treatments

Islatravir plus doravirine may offer new dual therapy option

News
25 July 2019
Treatment simplification strategies

Four days on, three days off HIV treatment as effective as continuous therapy, French study finds

News
25 July 2019
Starting treatment

US regulators approve new two-drug combination pill for HIV

News
11 April 2019
Treatment simplification strategies

Viral suppression maintained with alternate-day dosing of efavirenz/tenofovir/emtricitabine

News
1 April 2019
Injectable & long-acting HIV treatment

Long-acting injectable treatment maintains viral suppression

News
8 March 2019